"An unprecedented capability to directly measure, monitor, and understand molecular interactions of pathogenic agents and the immune system."
  

 


About Anven Biosciences

Pathway-specific Therapeutics and Diagnostics for Alzheimer’s disease

Recent discoveries in biomimetic chemistry have enabled highly effective new approaches to definitively isolate the cause of disease and directly link gene-epitope-antibody relationships for systematically stratified immunotherapeutics.

 To learn more about how Anven Biosciences and our “proxy antigen” technology can help you develop effective treatments for Alzheimer’s and other neurodegenerative diseases, please contact us:

 partnering@anvenbio.com